We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$342M
AUM Growth
+$14.4M
Cap. Flow
+$93.4K
Cap. Flow %
0.03%
Top 10 Hldgs %
35.1%
Holding
213
New
12
Increased
57
Reduced
106
Closed
7

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Healthcare 15.33%
3 Financials 12.81%
4 Industrials 8.55%
5 Communication Services 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
51
PayPal
PYPL
$49.9B
$1.78M 0.52%
23,967
+1,065
+5% +$72.9K
ETR icon
52
Entergy
ETR
$52.8B
$1.66M 0.49%
19,976
-5,065
-20% -$418K
CET
53
Central Securities Corp
CET
$1.55B
$1.65M 0.48%
34,502
+183
+0.5% +$8.31K
V icon
54
Visa
V
$682B
$1.65M 0.48%
4,638
-3
-0.1% -$1.05K
NVS icon
55
Novartis
NVS
$293B
$1.63M 0.48%
13,508
-631
-4% -$71.1K
VRTX icon
56
Vertex Pharmaceuticals
VRTX
$123B
$1.61M 0.47%
3,622
-121
-3% -$55.8K
CNC icon
57
Centene
CNC
$32.8B
$1.56M 0.46%
28,797
-3,715
-11% -$218K
BDX icon
58
Becton Dickinson
BDX
$43.6B
$1.51M 0.44%
8,783
+305
+4% +$55.9K
UNH icon
59
UnitedHealth
UNH
$387B
$1.5M 0.44%
+4,819
New +$1.84M
KO icon
60
Coca-Cola
KO
$351B
$1.45M 0.42%
20,500
-1,718
-8% -$122K
NVO
61
Novo Nordisk
NVO
$223B
$1.42M 0.42%
20,599
+9,510
+86% +$647K
AVGO icon
62
Broadcom
AVGO
$1.76T
$1.41M 0.41%
5,130
-670
-12% -$145K
MEDP icon
63
Medpace
MEDP
$15.4B
$1.38M 0.4%
4,391
+140
+3% +$42K
GILD icon
64
Gilead Sciences
GILD
$167B
$1.32M 0.38%
11,864
-270
-2% -$28.7K
WIW
65
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$513M
$1.31M 0.38%
149,138
-6,452
-4% -$55.4K
GD icon
66
General Dynamics
GD
$99.7B
$1.3M 0.38%
4,467
-36
-0.8% -$9.91K
BAB icon
67
Invesco Taxable Municipal Bond ETF
BAB
$1.04B
$1.27M 0.37%
48,002
TECH icon
68
Bio-Techne
TECH
$11.2B
$1.25M 0.37%
24,302
-584
-2% -$29.3K
VTV icon
69
Vanguard Value ETF
VTV
$186B
$1.25M 0.36%
7,067
-35
-0.5% -$5.91K
STIP icon
70
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$1.24M 0.36%
12,037
+1,460
+14% +$150K
JPM icon
71
JPMorgan Chase
JPM
$907B
$1.22M 0.36%
4,194
-64
-2% -$16.3K
LMT icon
72
Lockheed Martin
LMT
$117B
$1.21M 0.35%
2,614
-10
-0.4% -$4.68K
DIS icon
73
Walt Disney
DIS
$170B
$1.18M 0.34%
9,499
-6,625
-41% -$688K
LHX icon
74
L3Harris
LHX
$52.5B
$1.18M 0.34%
4,686
-224
-5% -$51.5K
ADP icon
75
Automatic Data Processing
ADP
$102B
$1.17M 0.34%
3,806

Similar funds

Roberts, Glore & Co's Q2 2025 Portfolio in Review

As of Q2 2025, Roberts, Glore & Co held 213 positions worth $342M, up 4.4% from $328M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Roberts, Glore & Co's Q2 2025 filing shows 12 new, 57 increased, 106 reduced and 7 closed positions. Its largest new stake was UnitedHealth: 4,819 shares worth $1.5M. The largest sale was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.77M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q2 2025 buy was UnitedHealth: 4,819 shares worth $1.5M.
  • Roberts, Glore & Co added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q2 2025, an estimated $758K increase.
  • Roberts, Glore & Co's biggest Q2 2025 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.77M.
  • Roberts, Glore & Co fully exited Discover Financial Services in Q2 2025, selling an estimated $256K.
  • Roberts, Glore & Co's ten largest holdings make up 35% of its $342M portfolio in Q2 2025.
  • Roberts, Glore & Co opened 12 new positions and closed 7 in Q2 2025.
  • Roberts, Glore & Co's portfolio value rose 4.4% quarter-over-quarter to $342M.

Based on Roberts, Glore & Co's 13F filing for Q2 2025, filed 7 Aug 2025.